Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer

Equality Impact Assessment (Guidance development) (PDF 156 KB)

Final draft guidance

Public committee slides (PDF 1.19 MB)

Final appraisal document Managed access agreement (PDF 438 KB)

Final appraisal document (PDF 271 KB)

Committee papers (PDF 10.13 MB)

Equality impact assessment (Scoping) (PDF 123 KB)

Final scope (PDF 260 KB)

Final stakeholder list (PDF 210 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 229 KB)

Draft scope post referral (PDF 232 KB)

Draft matrix post referral (PDF 209 KB)